| scholarly article | Q13442814 |
| P50 | author | Min-Jong Kang | Q37829106 |
| Michael R. Blackburn | Q48592114 | ||
| Chun Geun Lee | Q56810022 | ||
| P2093 | author name string | Jack A Elias | |
| Zhou Zhu | |||
| Hays W J Young | |||
| Janci L Chunn | |||
| Suman K Banerjee | |||
| P2860 | cites work | International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | Q28209239 |
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Interleukin-13: central mediator of allergic asthma | Q28291712 | ||
| Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency | Q28506465 | ||
| Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion | Q28507222 | ||
| Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice | Q28509639 | ||
| Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells | Q28510179 | ||
| Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction | Q28511939 | ||
| Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice | Q28587434 | ||
| 5' flanking sequences of the murine adenosine deaminase gene direct expression of a reporter gene to specific prenatal and postnatal tissues in transgenic mice | Q28593195 | ||
| Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney | Q30304269 | ||
| Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection | Q30307082 | ||
| The cardiac effects of adenosine | Q30459907 | ||
| The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group | Q33607993 | ||
| Airway remodeling in asthma | Q33753444 | ||
| Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma | Q33771430 | ||
| An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response | Q33853821 | ||
| The use of adenosine deaminase and adenosine deaminase isoenzymes in the diagnosis of tuberculous pleuritis | Q33982418 | ||
| Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema | Q34457903 | ||
| Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma | Q35764956 | ||
| Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells | Q37175389 | ||
| How does adenosine inhibit transmitter release? | Q39473010 | ||
| Potentiation of mast cell mediator release by adenosine | Q40135760 | ||
| The T cell response to secreted antigens of Mycobacterium tuberculosis | Q40505189 | ||
| Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis | Q40810490 | ||
| Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production | Q40849898 | ||
| Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung | Q41068693 | ||
| Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. | Q41151273 | ||
| Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects | Q41858531 | ||
| Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). | Q42101278 | ||
| Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse | Q42468017 | ||
| Transcriptional and post-transcriptional regulation of monocyte chemoattractant protein-3 gene expression in human endothelial cells by phorbol ester and cAMP signalling | Q42487447 | ||
| IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling | Q42518399 | ||
| Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives | Q42572532 | ||
| Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. | Q43594133 | ||
| Gene expression profiling in inflammatory airway disease associated with elevated adenosine | Q43855593 | ||
| Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis | Q44160763 | ||
| Adenosine A3 receptor expression and function in eosinophils | Q48050447 | ||
| Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways | Q48294439 | ||
| Effects of adrenergic agonists and adenosine on cholinergic neurotransmission in human tracheal smooth muscle | Q69366443 | ||
| Renal effects of 2-chloroadenosine and their antagonism by aminophylline in anesthetized rats | Q70406085 | ||
| Airway responsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease is determined by smoking | Q70583732 | ||
| Regulation and function of adenosine deaminase in mice | Q71487737 | ||
| Interleukin-13 and interleukin-4 are coexpressed in atopic asthma | Q71747952 | ||
| A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) | Q72034277 | ||
| Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor | Q72317964 | ||
| Airway eosinophilia in chronic bronchitis during exacerbations | Q72785478 | ||
| Adenosine in bronchoalveolar lavage fluid in asthma | Q72796936 | ||
| Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis | Q73076887 | ||
| The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities | Q74046235 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 332-344 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway | |
| P478 | volume | 112 |
| Q28510918 | A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury |
| Q37259865 | A semiautomated framework for integrating expert knowledge into disease marker identification |
| Q36890036 | A2B adenosine receptors regulate the mucus clearance component of the lung's innate defense system |
| Q42141388 | A3 adenosine receptor signaling contributes to airway mucin secretion after allergen challenge |
| Q36980497 | A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis |
| Q35546429 | Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis |
| Q36879416 | Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. |
| Q35190917 | Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. |
| Q40339055 | Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells |
| Q30434875 | Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells |
| Q39004042 | Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases |
| Q91623088 | Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema |
| Q33552900 | Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease |
| Q34393135 | Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation |
| Q35085245 | Adenosine in fibrosis. |
| Q35630498 | Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells |
| Q40369096 | Adenosine induces fibronectin expression in lung epithelial cells: implications for airway remodeling |
| Q34576595 | Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis |
| Q50086989 | Adenosine metabolism, immunity and joint health. |
| Q84308346 | Adenosine receptors and asthma |
| Q35263957 | Adenosine receptors and fibrosis: a translational review |
| Q34440546 | Adenosine receptors and vascular inflammation |
| Q37599075 | Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease |
| Q37101136 | Adenosine regulation of cystic fibrosis transmembrane conductance regulator through prostenoids in airway epithelia |
| Q37345181 | Adenosine signaling and the regulation of chronic lung disease |
| Q38103933 | Adenosine signaling pathways as potential therapeutic targets in respiratory disease |
| Q28748902 | Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis |
| Q37874185 | Animal models of airway diseases |
| Q33868549 | Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice |
| Q37644773 | A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice |
| Q37284017 | Bench-to-bedside review: adenosine receptors--promising targets in acute lung injury? |
| Q44147553 | Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models. |
| Q36860320 | CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. |
| Q36013719 | Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5' elements |
| Q95839279 | Comparison of biochemical parameters and chemokine levels in pleural fluid between patients with anergic and non-anergic tuberculous pleural effusion |
| Q38487303 | Conversion of Th17-type into Th2-type inflammation by acetyl salicylic acid via the adenosine and uric acid pathway in the lung |
| Q30423015 | Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury |
| Q37502960 | Diagnosis and management of asthma in older adults |
| Q36713583 | Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. |
| Q40773539 | ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo |
| Q34551159 | Ebselen is a potent non-competitive inhibitor of extracellular nucleoside diphosphokinase |
| Q34779773 | Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells |
| Q36780402 | Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor |
| Q37181414 | Evaluation of Serum Adenosine Deaminase in Cystic Fibrosis Patients in an Iranian Referral Hospital |
| Q37101130 | Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice |
| Q36467021 | Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis |
| Q37716974 | Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis. |
| Q37293104 | Finding better therapeutic targets for patients with asthma: adenosine receptors? |
| Q28512453 | Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice |
| Q38046124 | Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis |
| Q35528026 | Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor |
| Q39793327 | IL-13 and adenosine: partners in a molecular dance? |
| Q30480054 | IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17 |
| Q26859510 | IL-4 and IL-13 signaling in allergic airway disease |
| Q37596443 | Inflammation promotes airway epithelial ATP release via calcium-dependent vesicular pathways. |
| Q36960799 | Influenza A virus inhibits alveolar fluid clearance in BALB/c mice |
| Q40905189 | Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2. |
| Q47548202 | Inhibitory effect of naringenin via IL-13 level regulation on thymic stromal lymphopoietin-induced inflammatory reactions. |
| Q35106452 | Integrating mechanisms of pulmonary fibrosis |
| Q34696722 | Interleukin 13 and the beta-adrenergic blockade theory of asthma revisited 40 years later |
| Q35652268 | Interleukin-13 in asthma pathogenesis |
| Q27329908 | Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury |
| Q43067929 | Local administration of uridine suppresses the cardinal features of asthmatic airway inflammation |
| Q40366649 | Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells |
| Q37348370 | Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters |
| Q42701983 | Microarray Analysis of Gene Expression Profiles in Response to Treatment with Melatonin in Lipopolysaccharide Activated RAW 264.7 Cells |
| Q48308531 | Neuroinflammation after neonatal hypoxia-ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult |
| Q53626209 | Nucleotides induce IL-6 release from human airway epithelia via P2Y2 and p38 MAPK-dependent pathways. |
| Q36691126 | Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine |
| Q37297950 | Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor |
| Q28383555 | Response of Differentiated Human Airway Epithelia to Alcohol Exposure and Klebsiella Pneumoniae Challenge |
| Q28585044 | Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury |
| Q37203479 | Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism |
| Q38271409 | Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis II. Modifications to the ribofuranosyl moiety |
| Q36539636 | Sustained adenosine exposure causes lung endothelial barrier dysfunction via nucleoside transporter-mediated signaling |
| Q36832901 | The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease |
| Q92999338 | The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases |
| Q43261411 | The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma |
| Q30436868 | The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion |
| Q46837128 | The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin. |
| Q36240118 | The future of asthma therapy: integrating clinical and experimental studies |
| Q37874187 | Therapeutic applications |
| Q37689793 | Therapeutic potential of adenosine receptor antagonists and agonists |
| Q37343990 | Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of rho- and Ca2+-dependent signaling pathways |
| Q24654972 | Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling |
| Q37811063 | Transgenic modelling of cytokine polarization in the lung |
| Q27011823 | Treatment of allergic asthma: modulation of Th2 cells and their responses |
| Q38835390 | Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis. |
Search more.